← Leaderboards
Justin R. Ortiz
University Of Maryland Baltimore
$1,821,681
Attributed
$1,821,681
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $771.6K · FY2020–23$1M$750K$500K$250K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$1,821,681 · 1
By mechanism
U01$1,821,681 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Lijuan Yuan$3,888,254
- Marcelo B. Sztein$36,733,861
- Hanping Feng$19,880,798
- Wilbur H. Chen$12,119,388
- Carol Tacket$3,869,777
Others in their field
Other Emerging Leaders on “Active Comparator”
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Ionut Bebu · George Washington University$17,270,990
- Barbara Halina Braffett · George Washington University$17,270,990
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,093,619
- Manish Ishwar Shah · Baylor College Of Medicine$13,280,421
- Mark Brian Reed · San Diego State University$13,246,314
Research focus
Active ComparatorAdultAdverse EventAdjuvantAntibodiesAntibody ResponseAntigensBloodB-LymphocytesAgedCd8-Positive T-LymphocytesCell Mediated Immune ResponseCellsCell SurfaceCellular ImmunityChemokineClinical TrialsCytokineData ManagementDesignDoseDouble-Blind MethodEnrollmentEnsure
Grant awards (4)
Addressing unanticipated events for Intranasal Influenza H5 Vaccine Trial$113,531
U01 · FY2023 · AI · contact PI
Addressing unanticipated events for Intranasal Influenza H5 Vaccine Trial$167,385
U01 · FY2022 · AI · contact PI
A Phase I Randomized Clinical Trial of a Novel Mucosal Recombinant H5 Influenza Vaccine with Nanoemulsion Adjuvant Followed by Parenteral Boost of Licensed Inactivated Influenza A H5N1 Vaccine$771,638
U01 · FY2021 · AI · contact PI
A Phase I Randomized Clinical Trial of a Novel Mucosal Recombinant H5 Influenza Vaccine with Nanoemulsion Adjuvant Followed by Parenteral Boost of Licensed Inactivated Influenza A H5N1 Vaccine$769,127
U01 · FY2020 · AI · contact PI